Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Foghorn Therapeutics Inc. | Director | Common Stock | 3.33M | $27.5M | $8.25 | Aug 31, 2022 | Indirect |
Foghorn Therapeutics Inc. | Director | Common Stock | 295K | $2.43M | $8.25 | Aug 31, 2022 | Direct |
Foghorn Therapeutics Inc. | Director | Stock Options (Right to buy) | 12.5K | $38.3K | $3.06 | Aug 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FHTX | Foghorn Therapeutics Inc. | Aug 31, 2022 | 0 | $0 | 4 | Sep 2, 2022 | Director |
FHTX | Foghorn Therapeutics Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director, 10%+ Owner |
FHTX | Foghorn Therapeutics Inc. | Dec 14, 2021 | 1 | $0 | 4 | Dec 16, 2021 | Director, 10%+ Owner |
FHTX | Foghorn Therapeutics Inc. | Jul 13, 2021 | 1 | $0 | 4 | Jul 14, 2021 | Director, 10%+ Owner |